Tanner Harrah, DO
Sports Medicine · San Dimas, CANPI 1992169437
Payments from drug & device makers
Across 138 payments — averaging $82.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Stryker$2K
- Micromed Inc$1K
- Zimmer Biomet$732
- Vital Orthopedics LLC$429
- Amgen$352
- plus $2K from 15 others
What the payments were for
- Travel & lodging$8588%
- Food & beverage$5,48848%
- Education$4,97744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 23 | $4,366 |
| Stryker | 38 | $2,388 |
| Micromed Inc | 1 | $1,286 |
| Zimmer Biomet | 12 | $732 |
| Vital Orthopedics LLC | 2 | $429 |
| Amgen(2 entities) | 10 | $352 |
| Ossur Americas, Inc. | 5 | $260 |
| Johnson & Johnson | 4 | $259 |
| Linvatec Corporation | 11 | $220 |
| Smith+Nephew | 6 | $198 |
| Bioventus LLC | 7 | $195 |
| Globus Medical | 3 | $192 |
| Sportstek Medical, Inc | 1 | $85 |
| AstraZeneca | 4 | $77 |
| Kowa Pharmaceuticals America, Inc. | 4 | $74 |
| Baxter Healthcare | 1 | $61 |
| Empire Medical, Inc | 2 | $60 |
| Acera Surgical, Inc. | 1 | $25 |
| Si-bone, Inc. | 1 | $24 |
| Solventum Corporation | 1 | $20 |
| Avanos Medical | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,089
- NA$224
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$175
- TRIATHLON$168
- EVENITY$150
- Persona$149
- 1788$146
- Distal Femur Plate System$142
- Juggerknotless Soft Anchor$117
- Unloader One X$109
How this compares
$11,323 in reported general payments places this provider in the 70th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 33 | $984 |
| Naproxen | 34 | $345 |
| Ibuprofen | 41 | $316 |
| Oxycodone Hcl | 50 | $302 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $289 |
| Cefadroxil | 42 | $206 |
| Gabapentin | 14 | $175 |
| Cephalexin | 13 | $108 |
| Meloxicam | 33 | $79 |
| Diclofenac Sodium | 13 | $58 |
| Tramadol Hcl | 23 | $40 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in San Dimas
- Neal ElattracheLos Angeles$51M
- Nathaniel CohenLos Gatos$6.4M
- Thomas KnappSanta Monica$2.5M
- Seth ShermanStanford$1.8M
- Michael FreehillStanford$1.7M
- Deryk JonesSan Carlos$1.6M
- Allan MishraMenlo Park$1.5M
- Heinz Hoeneckela Jolla$1.4M
- Marc SafranPalo Alto$1.2M
- Stephan YacoubianBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.